Correction: Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway

Oncogene. 2020 Oct;39(41):6511. doi: 10.1038/s41388-020-01440-7.

¹ State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
² Qi Dong Liver Cancer Institute, Qi Dong, Jiangsu Province, China.
³ Cancer Institute of Guangxi, Nanning, China.
⁴ State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. htian@shsci.org.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.